3
Announcements
Trials
Browse
Landscape
Status
Recruiting
3
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Breast Neoplasms
115
Carcinoma, Non-Small-Cell Lung
103
Prostatic Neoplasms
90
Neoplasms
74
Multiple Myeloma
73
Lung Neoplasms
64
Colorectal Neoplasms
50
Leukemia, Myeloid, Acute
46
Neoplasm Metastasis
43
Lymphoma
39
Pancreatic Neoplasms
38
Melanoma
38
Lymphoma, Non-Hodgkin
36
Carcinoma, Renal Cell
36
Ovarian Neoplasms
34
Leukemia, Lymphocytic, Chronic, B-Cell
33
Squamous Cell Carcinoma of Head and Neck
31
Urinary Bladder Neoplasms
30
Hematologic Neoplasms
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Endometrial Neoplasms
26
Uterine Cervical Neoplasms
25
Carcinoma, Hepatocellular
25
Triple Negative Breast Neoplasms
24
Sarcoma
24
Glioma
24
Stomach Neoplasms
22
Head and Neck Neoplasms
22
Lymphoma, Large B-Cell, Diffuse
21
Brain Neoplasms
21
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Venous Thromboembolism
×
30 days
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled